Cecilia Calderón, general director at Vigpharma, highlights how the national pharmacovigilance and technovigilance regulations have been evolving during the last five years as well as showcasing the added value of Vigpharma to help both public and private institutions keep pace with such dynamism.
Ms. Calderón, you have more than 13 years of experience in leading pharmaceutical companies. What triggered you to found your own company in 2014?
"Our biggest achievement has been to gain the confidence from the public and private sector in Mexico, and remain a reliable partner for the industry."
